Sep 10, 2021

2021 PathMaker Programs for Cancer Research

This summer, Huntsman Cancer Institute welcomed back its PathMaker Programs for Cancer Research. Sixteen students and four secondary school science teachers learned valuable lessons while sharing amazing experiences together.

Jun 23, 2021

Proton Therapy Opens in Utah

Patients, doctors, scientists, donors, and community members gathered on June 23, 2021 to mark the opening of a major new resource for cancer care in Utah. The Senator Orrin G. Hatch Proton Therapy Center at Huntsman Cancer Institute (HCI) is the first of its kind in the Mountain West and one of only 37 such centers nationwide.

Oct 27, 2020

Letter of Hope: Breast and Ovarian Cancer Research in the Varley Lab

You might not see us during your visit to Huntsman Cancer Institute, but we want to let you know that we are working hard in the Varley Lab in the HCI research building next door. We conduct research that improves the treatment and care of patients like you. We are a small group of dedicated young men and women who are developing new strategies to diagnose and treat breast and ovarian cancer.

Oct 22, 2020

Letter of Hope: Breast Cancer Research in the Welm Labs

Dear patients, please know this as you go through your breast cancer treatment journey. The dedicated technical staff, PhD students, and postdoctoral fellows in the Welm Labs continue to work hard every day (and night!) to bring new hope to people with metastatic breast cancer through innovative research, always with patients in mind.

Jul 21, 2020

Huntsman Cancer Institute Receives Renewal of Prestigious Designation from the National Cancer Institute

The National Cancer Institute has renewed the designation of Huntsman Cancer Institute (HCI) at the University of Utah as a Comprehensive Cancer Center, the highest federal rank possible for a cancer research organization. This grant awards HCI more than $29 million over seven years, an increase of 84% in annual funding from the previous award cycle.

Jun 26, 2020

A Study of Early-Onset Colorectal Cancer in Young Adult Men Reveals “Hotspots” of Death in the United States

Over the last three decades, colorectal cancer survival in the United States has improved significantly. But in young people incidence and mortality due to colorectal cancer are on the rise. Even among patients with early-stage colorectal cancer, racial disparities have grown more pronounced, with survival after colorectal cancer diagnosis poorer among African Americans compared with whites. Charles R. Rogers, PhD, MPH, MS, is working to better understand these factors in young people with colorectal cancer in order to help improve outcomes and reduce related disparities from this preventable disease.

May 07, 2020

Proton Accelerator Arrives at Huntsman Cancer Institute

Construction at the Senator Orrin G. Hatch Proton Therapy Center at Huntsman Cancer Institute is well underway. On March 28, a 15-ton proton accelerator arrived and was installed at the future center. This marks a major milestone for the project slated for a December 2020 debut.

Mar 04, 2020

Paving the Way for Indigenous Scholars

The PathMaker Program definitely had a significant impact on my career path. It was what opened the door to the research world and provided me with the support I needed even after completing the program. I learned that even though my internship ended, the relationships and contacts I gained in the program did not. PathMaker has helped me in every step of my career, and I will be forever grateful.

Mar 01, 2020

Message from Neli Ulrich

Every day at Huntsman Cancer Institute (HCI), members of our more than 200 cancer research teams enter the doors with a strong sense of responsibility to make a difference in the cancer challenges we face. They bring expertise from all over the world and are recognized for their exceptional collaboration.

Mar 01, 2020

Mensaje de Neli Ulrich

Todos los días en Huntsman Cancer Institute (HCI, por sus siglas en inglés), los miembros de nuestros más de 200 equipos de investigación del cáncer entran por la puerta con un fuerte sentido de responsabilidad para marcar la diferencia en los desafíos que enfrentamos respecto al cáncer. Traen experiencia de todo el mundo y son reconocidos por su colaboración excepcional.

Feb 25, 2020

Huntsman Cancer Institute Translational Scholars: Courtney Scaife, MD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Courtney Scaife, MD, was recently honored with a Huntsman Translational Scholar award.

Feb 24, 2020

Huntsman Cancer Institute Translational Scholars: Benjamin L. Maughan, MD, PharmD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Benjamin L. Maughan, MD, PharmD, was recently honored with a Huntsman Translational Scholar award.

Feb 21, 2020

Chasing—and Catching—His Dreams

To say that the PathMaker Program made an impact on my life would be a huge understatement. I learned so much from my PathMaker experience, I honestly could write a book about it. Because of the skills I learned, the connections I made, and the amazing mentorship I received, the program instilled in me a drive to continue to chase my dreams.

Jan 13, 2020

Huntsman Cancer Institute Translational Scholars: Randy Jensen, MD, PhD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Randy Jensen, MD, PhD, was recently honored with a Huntsman Translational Scholar award.

Oct 01, 2019

Solving a Family Cancer Mystery: Li-Fraumeni Syndrome

When Kiera Jorgensen was diagnosed with cancer at the age of 19, she fought not only sarcoma, but also a mystery that had loomed over her family for generations. Now years out of treatment, Kiera has answers and is conducting research to help families like hers better understand a rare genetic mutation.

Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Jun 12, 2019

Determining Risk of Recurrence in Triple-Negative Breast Cancer

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah.

Jun 06, 2019

Caring for Patients with a Family History of Pancreatic Cancer

Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas cancer screening strategies for certain patients with a family history of the disease.

May 31, 2019

International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results

Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.

May 29, 2019

Art Meets Science

Bryan Welm, PhD, has found a unique way to merge his love for science and art.

May 13, 2019

New Insights into Treatment Targets for Men with Advanced Prostate Cancers

In the largest study of its kind, more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies

Apr 24, 2019

How Our Researchers and Physicians Work to End Health Disparities

To recognize National Minority Health Month, we spoke to two of our staff about their on-the-ground work to address health disparities, and why they value diversity in cancer research and care.

Apr 23, 2019

Air Pollution Poses Risks for Childhood Cancer Survivors

Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer, according to a study conducted by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and published in the International Journal of Environmental Research and Public Health.

Apr 08, 2019

Huntsman Cancer Institute Announces Interim Clinical Leaders

Two physicians at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) are stepping into interim clinical leadership roles.

Apr 01, 2019

Huntsman Cancer Institute Contributes to Colorectal Cancer Research Studies

Huntsman Cancer Institute contributed to two research studies involving how microbes living in and on our body play a role in the development of colorectal cancer.

Mar 13, 2019

How Barbershops Will Play a Role in Reducing Colorectal Cancer Disparities among African-American Men

African-American men are more likely to die from colon cancer than any other racial group. That fact led a researcher at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) to begin a long-term project to understand why.

Mar 12, 2019

Huntsman Translational Scholars: Matthew Poppe, MD

Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in the laboratory and apply them to solve clinical problems and benefit patients through new diagnostic and therapeutic approaches.

Mar 04, 2019

Promising New Pancreatic Cancer Treatment Moves Forward

A study published today in the journal Nature Medicine led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) describes a new therapeutic approach with potential for patients with pancreatic cancer. These researchers discovered a combination drug therapy that may effectively combat the disease. HCI researchers first observed anti-cancer impacts in a laboratory setting and, subsequently, in its first use in a human patient.

Mar 01, 2019

Joining Forces to Eradicate HPV-Related Cancers

HPV vaccination rates still lag far behind other recommended vaccines, and Utah has one of the lowest rates in the nation. Only about 34 percent of Utah adolescents have completed the vaccine series, compared to the national average of 50 percent. Huntsman Cancer Institute is joining forces with experts across the country to change those statistics.

Mar 01, 2019

Exercise for Improved Outcomes

The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can improve long-term outcomes after lung cancer surgery.

Mar 01, 2019

Pancreas Discovery Moves from Lab to Clinic

In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that had not been used in combination before to treat pancreatic tumors. The results were promising and they were able to move from the lab to clinical trial quickly. A clinical trial to test the safety and effect of this drug combination in pancreatic cancer is now underway at HCI and planned at other sites around the United States.

Mar 01, 2019

Breaking Ground for Proton Therapy

When construction is complete in 2021, Huntsman Cancer Institute will implement the latest advance in proton therapy, called intensity-modulated proton therapy. Proton therapy is the favored approach for many tumors in and around vital structures such as the spinal cord and brain stem. It is also the preferred treatment for certain childhood cancers. We are committed to bringing cutting-edge care to our patients, and proton therapy will be the next step in that promise.

Mar 01, 2019

Clinical Trials: A Look at Recent Progress

Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ways to prevent, diagnose, or treat cancer. At any given time, Huntsman Cancer Institute has an average of 200 clinical trials open to cancer patients.

Mar 01, 2019

Finding Familial Cancer Risk

In 2018, a team of researchers at Huntsman Cancer Institute received a prestigious National Cancer Institute Cancer Moonshot grant. The grant will fund studies about ways to identify patients who may benefit from genetic counseling and services.

Mar 01, 2019

Working Together To Engage Every Community

In summer 2018, Huntsman Cancer Institute established a Community Advisory Board (CAB) to increase community outreach and engagement and address health disparities through collaboration. The 38 CAB members represent government organizations, safety-net health care and health systems, comprehensive cancer programs, community organizations focused on the underserved, business and religious leaders, elected officials, and cancer patients, caregivers, and survivors.

Mar 01, 2019

A Passion for Advancing Research and Improving Patient Care

HCI patient Clark Stringham felt like he was running out of time with his diagnosis of advanced prostate cancer. He credits a clinical trial and his oncologist, Neeraj Agarwal, MD, with saving his life.

Mar 01, 2019

Helping Patients Feel at Home

Huntsman Cancer Institute launched a new service in the summer of 2018 called Huntsman at Home, which brings HCI-quality care into the homes of patients. The Huntsman at Home team assesses and treats issues caused by cancer or its treatments so patients can leave the hospital sooner or avoid going in at all.

Mar 01, 2019

Together We Care Compassionately

Approximately 500 patients visit the outpatient clinics and infusion center at Huntsman Cancer Institute each day. Our patients rely on our clinical teams and staff to provide safe, efficient, and high quality care during each clinic visit. In this letter from Don Milligan, director of outpatient services, highlights recent efforts to provide the best care possible.

Feb 11, 2019

Talks with Docs: Ignacio Garrido-Laguna, GI Oncologist

Ignacio Garrido-Laguna, MD, PhD, is a gastrointestinal oncologist with a special interest in pancreas cancer. In this interview, he tells us about his home and his medical training in Spain, including how it is similar to Utah, as well as his vision for the future of pancreas cancer.

Feb 08, 2019

Last Year’s Biggest Advances in Cancer Research

The American Society of Clinical Oncology recently published Clinical Cancer Advances, their 2019 annual report on the progress against cancer. The report examines the most transformative research of the past year and looks ahead to future research priorities. Two physician-scientists from Huntsman Cancer Institute contributed to the report.

Feb 04, 2019

New Study Shows Cost Effectiveness of Early Cancer Surveillance for Patients Who Have a High Risk of Developing Cancer

New research published today in the journal Pediatric Blood and Cancer shows how early cancer screening and surveillance in patients with Li-Fraumeni Syndrome (LFS) results in additional years of life, and is cost effective for third-party payers.

Jan 23, 2019

Talks with Docs: Neli Ulrich, Cancer Researcher

Cornelia Ulrich, MS, PhD, is director of Huntsman Cancer's Institute's NCI-Designated Comprehensive Cancer Center. She oversees nearly 200 cancer research teams and leads efforts to advance research in laboratory, clinical, and population science. Get to know Dr. Ulrich in this interview, where she speaks to us about the beginning of her career in Germany and how she relaxes after a day of juggling her many roles.

Jan 09, 2019

Huntsman Cancer Institute Helps Develop BRCA Exchange to Inform Understanding of Cancer Risk by Aggregating Data on Thousands of BRCA1 and BRCA2 Mutations

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) contributed to the development of a global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes. This resource, called the BRCA Exchange, is now available to the public. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1/BRCA2 data. The new resource will allow clinicians to review expert classifications of variants in these major cancer predisposition genes as part of their individual assessment of cancer prevention, screenings, and interventions for patients at higher risk for breast, ovarian, and certain other cancers.

Jan 07, 2019

Huntsman Translational Scholars: Thomas Varghese Jr., MD, MS

HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Thomas Varghese Jr, MD, MS, was recently honored with a Huntsman Translational Scholar award.

Dec 13, 2018

Huntsman Cancer Institute Launches Innovative Service Providing Cancer Care at Home

Huntsman Cancer Institute at the University of Utah has launched a unique new service called Huntsman at Home. This service brings HCI-quality care into the homes of HCI patients, whose medical needs range from symptom management to physical therapy after cancer surgery to end-of-life care. Huntsman at Home may also allow patients to be discharged from the HCI cancer hospital sooner by enabling them to receive follow-up care in their own home.

Dec 10, 2018

Researchers Develop Personalized Medicine Tool for Inherited Colorectal Cancer Syndrome Risk

An international team of researchers led by Huntsman Cancer Institute at the University of Utah has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes that are likely to be responsible for causing symptoms of the disease. The results were published in the journal Genetics in Medicine.

Nov 20, 2018

The Pancreatic Cancer Collective awards $7 million in first-round “New Therapies Challenge” Grants

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today. Each team will receive up to $1 million in initial funding, with $4 million per team for clinical studies awaiting the most successful projects in the second round.

Nov 20, 2018

Huntsman Cancer Institute Breaks Ground for Utah’s First Proton Therapy Center

Officials at Huntsman Cancer Institute at the University of Utah began construction on a project that will house the region’s first proton therapy center and announced the new center will be named in honor of United States Senator Orrin G. Hatch. Cancer patients and loved ones joined leaders from HCI, Huntsman Cancer Foundation, and the university to mark the occasion.

Nov 15, 2018

Huntsman Cancer Institute Announces New Phase I Clinical Trial Director

Huntsman Cancer Institute at the University of Utah has appointed Ignacio Garrido-Laguna, MD, PhD, as director of its Phase I Clinical Trials unit. In this position, Garrido-Laguna will oversee all aspects of HCI’s Phase I clinical trials.

Nov 01, 2018

Lung Cancer Research Foundation Awards $1.95 Million in Research Grants

The Lung Cancer Research Foundation (LCRF) announced the awardees of its 2018 Scientific Grant Program today during the Thirteenth Annual Lung Cancer Awareness Luncheon, held at The Pierre in New York City. Through this program, LCRF awarded $1.95 million in research grants to 13 investigators for innovative research focused on the prevention, diagnosis, and treatment of lung cancer. LCRF received a record-breaking 201 grant applications, representing 116 institutions and 21 countries in 2018.

Oct 24, 2018

Utah Cancer Registry Receives Renewal from National Cancer Institute

Huntsman Cancer Institute and the University of Utah will receive up to $28 million over the next 10 years from the National Cancer Institute (NCI) to continue its participation in the NCI’s Surveillance Epidemiology and End Results program.

Oct 18, 2018

Breaking The Link Between Obesity and Gastrointestinal Cancers

By unraveling the link between obesity and gastrointestinal cancers, researchers hope to develop effective treatments and strategies for lowering cancer risk. A team of scientists at Huntsman Cancer Institute published a wide review of findings on the biological links between obesity and gastrointestinal cancers. They also examined studies on how diet, exercise, and other weight-related interventions may help reverse this connection.

Oct 18, 2018

Shedding Light on the Complex World of Prostate Cancer Treatment at the 2018 Cancer Summit

Many men feel overwhelmed by options when deciding how to treat their prostate cancer. To educate community members on this complex topic, Huntsman Cancer Institute joined our affiliate hospital St. John's Medical Center at the 2018 Cancer Summit to discuss advances in prostate cancer diagnosis and care.

Oct 17, 2018

Study Reveals Reasons Why African American Men Are Underrepresented in Prostate Cancer Research

African American men experience significant health disparities. They are almost twice as likely to be diagnosed with prostate cancer as white men, yet they are underrepresented in prostate cancer research. A new study by Charles R. Rogers, PhD, MPH, MS, CHES®, uncovers attitudes toward prostate cancer research among African American men and suggests strategies to increase participation in research. The study is included in a new collection of research on health disparities impacting African American men.

Oct 16, 2018

A Bad Influence: The Interplay between Tumor Cells and Immune Cells

Research at Huntsman Cancer Institute at the University of Utah yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment. The results were published today in Immunity and featured on the print cover of the journal.

Oct 15, 2018

Low-Dose Aspirin May Lower Risk of Ovarian Cancer

Women who reported recent, regular use of low-dose aspirin had a 23% lower risk of ovarian cancer when compared with women who did not regularly take aspirin, according to research led by Mollie Barnard, ScD, a postdoctoral fellow at Huntsman Cancer Institute.

Oct 11, 2018

Study Holds Promise for New Pediatric Brain Tumor Treatment

New research published in Nature Communications from scientists at Huntsman Cancer Institute at the University of Utah, in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both the initiation of cancer spreading and the self-renewal of cancer cells in medulloblastoma, a type of pediatric brain cancer.

Oct 04, 2018

Talks with Docs: Cindy Matsen, MD

At Huntsman Cancer Institute, Dr. Cindy Matsen helps provide patients with surgical options as they undergo treatment for their breast cancer. In this interview, we learn about the relationships she builds with her female patients and what they teach her every day.

Oct 02, 2018

Huntsman Cancer Institute and Grand Valley Oncology Begin Telemedicine Clinic for Blood and Bone Marrow Transplant Patients

Huntsman Cancer Institute at the University of Utah, in partnership with Grand Valley Oncology, recently opened a telemedicine clinic to serve blood and marrow transplant patients in Mesa County, Colorado and the surrounding areas. This service will bring cutting-edge care to remote communities without requiring the patient to travel long distances to Salt Lake City for follow-up appointments.

Sep 19, 2018

Huntsman Translational Scholars: Ignacio Garrido-Laguna, MD, PhD

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Ignacio Garrido-Laguna, MD, PhD, is a physician-scientist who treats patients with pancreatic cancer.

Sep 18, 2018

Talks with Docs: Deborah Stephens, DO

Dr. Deborah Stephens cares for patients with lymphoma and chronic lymphocytic leukemia and researches these diseases. In this episode of Talks with Docs, she shares the importance of caring for the whole patient and how becoming a parent has changed her.

Sep 11, 2018

Talks with Docs: Thomas Varghese, MD

Tom Varghese, MD, is a thoracic surgeon who treats patients with lung cancer at Huntsman Cancer Institute. But did you know he's also an amateur cartoonist who's passionate about gender equity in the medical field?

Sep 07, 2018

Huntsman Cancer Institute CEO Mary Beckerle, PhD, Honored by YWCA Utah

YWCA Utah has selected Mary Beckerle, PhD, CEO of Huntsman Cancer Institute, to receive the Outstanding Achievement Award in Medicine and Health. Beckerle will be honored today at the 30th annual YWCA Utah LeaderLuncheon.

Aug 10, 2018

Nurturing Future Cancer Researchers in the PathMaker Program

The PathMaker program is a stepping stone for students interested in a career in health sciences or STEM with backgrounds underrepresented in the biomedical workforce.

Aug 07, 2018

Research Identifies New Treatment Targets in Breast Cancer

Scientists at Huntsman Cancer Institute at the University of Utah, in collaboration with the Salk Institute for Biological Studies, have generated the first single cell resolution atlas of genes that control the formation of breast tissue. The atlas provides a comprehensive molecular map that will be used to help researchers understand how breast cancers form and to pinpoint new ways to prevent, diagnose, and treat the disease.

Aug 01, 2018

Study of Utah Lung Cancer Patients Finds Those Who Never Smoked May Have Genetic Predisposition for Cancer

Despite Utah's low smoking rate, lung cancer remains the leading cause of cancer death in Utah. In addition, lung cancer in people who have used tobacco and people who have never smoked behaves differently. Researchers at Huntsman Cancer Institute wanted to know why.

Jul 31, 2018

Huntsman Translational Scholars: Howard Colman, MD, PhD

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Howard Colman, MD, PhD is a physician-scientist specializing in the treatment of brain tumors and the diagnosis and management of neurologic complications of cancer.

Jul 13, 2018

Huntsman Cancer Institute Names Cornelia Ulrich as Director of its Cancer Research Center

Huntsman Cancer Institute at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment.

Jul 11, 2018

Huntsman Cancer Institute Researcher Receives Leadership Award from the National Cancer Institute

Huntsman Cancer Institute physician-scientist Ahmad Halwani, MD, has been selected by the National Cancer Institute to receive a Cancer Clinical Investigator Team Leadership Award. This award recognizes physician-scientists for their contributions to clinical cancer research. It also provides financial support for ongoing research and leadership development to enable recipients to further advance their clinical research careers.

Jul 09, 2018

Huntsman Translational Scholars: Adam Cohen, MD, MS

Huntsman Cancer Institute established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Adam Cohen, MD, MS, was recently honored with a Huntsman Translational Scholar award. He is a researcher and physician, specializing in neuro-oncology and breast oncology.

Jun 14, 2018

Huntsman Cancer Institute Physicians Attend and Share Expertise at National Cancer Meeting

“Delivering Discoveries: Expanding the Reach of Precision Medicine,” was the theme of the American Society of Clinical Oncology (ASCO) 2018 annual meeting held June 1-5, 2018 in Chicago. One of the largest scientific conferences in the world, the meeting brings together nearly 40,000 attendees and features thousands of studies about new ways to prevent, detect, and treat cancer.

Jun 11, 2018

Letter of Hope from the Gertz Lab

It is patients like you, your loved ones, and Dr. Gertz's parents who keep us motivated and excited to find ways to help in the fight against this terrible disease. We appreciate everything you do as patients—like donating samples and participating in clinical trials—and we want you to know that we are doing everything we can to help patients with breast and uterine cancer.

Jun 07, 2018

Huntsman Cancer Institute Partners with Nation’s Top Cancer Centers to Endorse Goal of Eliminating HPV Related Cancers in the United States

Nearly 80 million Americans—one out of every four people—are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.

May 30, 2018

Huntsman Cancer Institute and TGen receive $6.7 million grant to battle a hidden enemy

Often what kills cancer patients is not the cancer at its original or primary site, but its spread to secondary sites within the body, through a process called metastasis. In the case of breast cancer, the tumor often spreads to the bone, and it is this bone metastasis that results in intense pain and precedes spread to other organs.

May 23, 2018

Huntsman Translational Scholars: Deborah Stephens, DO

HCI established the Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of Hematology Clinical Trials at Huntsman Cancer Institute and is also an assistant professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.

May 18, 2018

Space Could Be the New Frontier for Cancer Research

On May 16, 2018, HCI hosted a NASA astronaut and a team from the Center for the Advancement of Science in Space to discuss the opportunity of researching cancer in space.

May 10, 2018

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients

Huntsman Cancer Institute announced today that it has been certified to offer both chimeric antigen receptor (CAR) T cell therapies recently approved by the U.S. Food and Drug Administration. The therapies are approved for types of aggressive blood cancers, including B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. HCI is one of a few locations nationwide, and the only in the Mountain West, approved to offer these new therapies to adult cancer patients.

May 09, 2018

Huntsman Translational Scholars: Theresa Werner, MD

HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Theresa Werner, MD, was recently honored with a Huntsman Translational Scholar award. She is the medical director of Clinical Trials and treats patients with gynecologic cancers.

May 08, 2018

Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations

Huntsman Cancer Institute at the University of Utah today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute to fund a clinical trial researching new and effective approaches to reduce tobacco use.

May 01, 2018

Persistence Pays Off in Discovery That Could Lead to Improved Treatment and Survivability of Patients with Brain Tumors

Gliomas are the most common type of central nervous system cancer but how these tumors develop is not fully understood. Sheri Holmen, PhD a researcher at Huntsman Cancer Institute and professor of surgery at the University of Utah just published the results of her research on gliomas in Cell Reports. The work is focused on a mutated gene that is a critical piece of the puzzle for glioma development, according to Holmen’s work.

Apr 27, 2018

Huntsman Cancer Institute Researchers Attend and Share Expertise at National Cancer Meeting

“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research annual meeting, which took place April 14-18 in Chicago. Huntsman Cancer Institute faculty and staff joined almost 22,000 other scientists, physicians, and patient advocates from around the world to share the latest findings in translational, clinical, and prevention-focused cancer research.

Mar 15, 2018

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

Huntsman Cancer Institute at the University of Utah has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society. The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.

Mar 13, 2018

Surprising Discovery Provides Insights into Aggressive Endometrial Cancers

New research from Huntsman Cancer Institute at the University of Utah indicates steroid and hormone receptors are simultaneously active in many endometrial cancer tissues. The findings, published today in the journal Cell Reports, yield insights about factors that contribute to more aggressive endometrial tumors.

Mar 08, 2018

Talks with Docs: Theresa Werner, MD

Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She talks with us about the optimistic women she treats in clinic and a stylish first lady of the United States she would trade lives with for a day.

Feb 27, 2018

New understanding of enzyme’s role in development of certain brain and spinal cord tumors

In a study recently published in Acta Neuropathologica, L. Eric Huang, MD, PhD, Huntsman Cancer Institute researcher and associate professor of neurosurgery at the University of Utah, and colleagues report on new findings in the function of an enzyme, IDH1, in the development of gliomas. Gliomas are life-threatening tumors of brain or spinal cord tissue, and this type of tumor affects approximately 25,000 people each year. As changes in IDH1 are found in the vast majority of gliomas, understanding the impact of IDH1 enzyme function is critical to advancing research in this disease.

Feb 15, 2018

Navigating Cancer at a Young Age

For many of young people, a cancer diagnosis is their first real medical issue. This was the case for Marina Pimentel, who was diagnosed with Hodgkin lymphoma, a type of blood cancer, at age 26. Marina worked with an AYA patient navigator to help her manage the complexities of cancer treatment and care.

Feb 15, 2018

Total Cancer Care: Coming Together to Find Cures

Christina Ratcliff enrolled in HCI's Total Cancer Care study, a partnership among patients, health care providers, and researchers to help accelerate cancer research and improve patient care.

Feb 15, 2018

Message from HCI's CEO

The West is known for its "can-do" spirit, for the willingness of people to work together. At Huntsman Cancer Institute, we strive to push the boundaries of cancer research and care and attain results beyond what we thought was possible. We've made a commitment to advance cutting-edge cancer research and care in the Mountain West region.

Feb 15, 2018

Bench to Bedside

Advancing discoveries made in the lab to medical treatments that can be used in patient care is complex and time-consuming. Commonly called clinical translation, this process can be thought of much like translating something from one language to another.

Feb 15, 2018

Developing Better Targeted Therapies

Targeted therapy in cancer treatment is often called personalized or precision medicine, according to the National Institutes of Health. Targeted therapies are designed to be more effective and less harmful than other approaches because the drugs are specially designed to meet the individual characteristics of each patient.

Feb 15, 2018

Seeding New Breakthroughs

At Huntsman Cancer Institute, our donors are inspired to give, and we are inspired by our donors. Their giving will seed the next new breakthroughs in cancer research, leading to life-saving treatments and, ultimately, eradicating cancer altogether.

Feb 15, 2018

Working in Harmony: New Insights into How Packages of DNA Orchestrate Development

New research from Huntsman Cancer Institute at the University of Utah illuminates aspects of how an early embryo, the product of fertilization of a female egg cell by a male sperm cell, can give rise to all the many cell types of the adult animal. The findings, published in the journal Cell, have significant implications for understanding how early development is orchestrated, and provides a mechanism for how parental environment might impact the expression of these genes in the offspring.

Feb 15, 2018

Training the Next Generation of Cancer Researchers

Over the years, there have been many landmark discoveries in the effort to eradicate cancer. Progress can only continue with well-trained and passionate researchers and physicians. Huntsman Cancer Institute faculty work with students of all ages to cultivate the next generation of scientists who will carry on this life-saving work.

Feb 01, 2018

Changes in genes involved in DNA repair and packaging linked to risk of multiple myeloma

Researchers have identified two gene regions that contribute to multiple myeloma, an inherited cancer that occurs in bone marrow, through a new method that makes use of human disease pedigrees. Nicola Camp and Rosalie Waller of Huntsman Cancer Institute at the University of Utah and colleagues report their findings February 1st in PLOS Genetics.

Jan 30, 2018

Smartphone App Shows Promising Results in Helping Young Cancer Patients Take Medications on Time

Remembering to take medication can be a struggle for anyone, but it’s usually a tougher challenge for teens and young adults with cancer. A recent study shows using a smartphone reminder app helps patients in this age group take medication as prescribed.

Jan 29, 2018

Huntsman Cancer Institute Selected as a National Cancer Institute Center for Patient-Derived Model Development

Huntsman Cancer Institute has been awarded a $2.4 million, two-year grant from the National Cancer Institute to help continue its research in breast cancer. Alana Welm, PhD and Bryan Welm, PhD, investigators at HCI, along with Michael Lewis, PhD, a colleague at Baylor College of Medicine, will use this new funding to serve as a Breast Cancer Patient-derived xenograft Development and Trials Center to research and test new drugs for breast cancer. This new Center is only one of four such Centers in the nation.

Jan 26, 2018

Early Career Researcher Receives Merit Award for Colorectal Cancer Research

Post-doctoral fellow Andreana Holowatyj, PhD, received an award for her work studying colorectal cancer in young adults from the Conquer Cancer Foundation of the American Society of Clinical Oncology.

Jan 17, 2018

A Centuries-Old Math Equation Used to Solve a Modern-Day Genetics Challenge

Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

Jan 09, 2018

Huntsman Cancer Institute CEO and Director Honored by National Cancer Institute

Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute at the University of Utah, is this year’s recipient of the Alfred G. Knudson Award in Cancer Genetics from the National Cancer Institute.

Dec 22, 2017

New Endowed Chair Holders at HCI

Huntsman Cancer Institute (HCI) is pleased to announce the appointment of two of our colleagues as holders of prestigious endowed chairs at the University of Utah. Endowed chairs recognize academic distinction, promote excellence, and provide funds for cutting-edge research.

Dec 05, 2017

Utah Breast Cancer Doctor Named on Forbes' "Physician Honor Roll"

Saundra Buys, MD, medical oncologist at Huntsman Cancer Institute (HCI) and a professor of medicine at the University of Utah was named by Forbes among the top breast cancer physicians in the country. Buys is one of only 27 in the nation to receive this recognition.

Nov 30, 2017

A Glass-Half-Full Approach to Lung Cancer in the McMahon Lab

Martin McMahon, PhD, and his research group study the genetic mutations that contribute to lung cancer. About 30% of lung cancers can now be treated based on the disease’s specific genetics. McMahon is hopeful that each subset of lung cancer will soon have its own precision treatment.

Nov 27, 2017

Huntsman Cancer Institute Researchers Trace Timeline of Tumor Evolution in Metastatic Breast Cancer Patients

A new study by researchers at Huntsman Cancer Institute (HCI) at the University of Utah observed how breast cancer tumors evolve over time and demonstrated how changes within tumors may contribute to the process by which cancers no longer respond to treatment. Further, the research identifies that some of these changes may be shared across certain treatment-resistant breast cancers. The study was published this month in Nature Communications.

Nov 27, 2017

Talks with Docs: Randy Jensen, MD, PhD

Dr. Randy Jensen—auto racer, canyoneer, triathlete, and neurosurgeon—chats with us about his many life adventures.

Nov 22, 2017

Risk for Aging-related Diseases Elevated Among Thyroid Cancer Survivors

Risk for aging-related diseases such as heart disease and diabetes was significantly higher among thyroid cancer survivors in Utah than it was among age-matched, cancer-free individuals, with those diagnosed before age 40 having the highest risk for some of the diseases, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research

Nov 15, 2017

HCI Trainee Receives NCI Graduate Diversity Supplement

Kali Dale, a graduate research assistant at HCI, was selected to receive the National Cancer Institute Graduate Diversity Supplement.

Nov 14, 2017

Huntsman Cancer Institute Expanding Access to Clinical Trials

All cancer treatments and medications that are used today, at one point, were clinical trials. Clinical trials can offer hope, particularly in a complex disease like cancer. But getting access to clinical trials can be difficult, especially if patients have to travel a long distance to a hospital that offers trials.

Nov 06, 2017

Huntsman Cancer Institute Study Identifies Enhanced Impact of Treatment for Hereditary Cancer Patients

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care. Recent findings published by researchers at Huntsman Cancer Institute at the University of Utah identified a promising prevention treatment for patients with FAP.

Oct 25, 2017

Huntsman Cancer Institute’s Researchers Develop New Method for Gene Silencing

A study published today in Cell Systems highlights a new research method using the recently developed CRISPR technique. In short, CRISPR is a technology that allows researchers to cut out a section of DNA that causes a disease, like cancer, and then replace the section with normal, healthy genes.

Oct 19, 2017

New Study Finds Childhood Cancer Survivors Commonly Stay at Jobs to Keep Health Insurance

The results of a national cancer survey find a significant number of childhood cancer survivors are worried about keeping their health insurance, to the point of letting it affect their career decisions. The findings were published today in JAMA Oncology. Anne Kirchhoff, PhD, investigator at Huntsman Cancer Institute (HCI) at the University of Utah and assistant professor of pediatrics, led the study. Her goal was to examine the prevalence of job lock in full-time, employed childhood cancer survivors. Job lock is when an employee stays at a job in order to keep work-related health insurance.

Oct 07, 2017

Talks with Docs: Jonathan Tward, MD, PhD

Jonathan Tward, MD, PhD, explains how he began his career as a radiation oncologist, what he's learned from his patients, and why he loves an unusual sport.

Oct 06, 2017

HCI Trainee Wins NCI Predoctoral to Postdoctoral Fellow Transition Award

Gurkan Mollaoglu, a graduate student in the Oliver Lab, received an F99 NCI Predoctoral to Postdoctoral Fellow Transition Award. This prestigious grant recognizes and supports outstanding graduate students who have demonstrated potential and interest in pursuing careers as independent cancer researchers.

Oct 05, 2017

New Research on Sperm Stem Cells has Implications for Male Infertility and Cancer

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah and collaborators at University of Utah Health (U of U Health) sheds light on the complex process that occurs in the development of human sperm stem cells. This is the first study to characterize the changes human sperm stem cells undergo as they mature. The results have implications for understanding male infertility as well as cancer development and were published today in the journal Cell Stem Cell.

Sep 22, 2017

Huntsman Cancer Institute Announces New Clinical Research Director

Huntsman Cancer Institute (HCI) at the University of Utah has announced David Gaffney, MD, PhD, as Senior Director for Clinical Research. In this position, Gaffney oversees HCI’s clinical research efforts which include more than 200 active clinical cancer trials at any given time.

Sep 01, 2017

Adipose Tissue May Affect Cancer Development in Multiple Ways

Review indicates need to further explore relationship between fat and cancer. Adipose tissue, or fat, may influence the development of cancer in diverse ways, depending on the type of fat and the location in the body, according to results of a systematic review published in Cancer Prevention Research, a journal of the American Association for Cancer Research

Jul 18, 2017

Study Shows Shorter Course of Radiation May Be a Safe and Convenient Option for Breast Cancer Patients after Mastectomy

Research published in the Journal of Clinical Oncology demonstrates that a shorter course of radiation may be a good option for breast cancer patients who need radiation following mastectomy. The Phase II clinical trial examined the safety of treating women with a three-week course of radiation instead of the traditional six weeks.

Jul 11, 2017

Cancer Researchers in Training: Studying What Makes Each Cell Unique

RNA modification is an area of cell biology few people have studied, and the idea of exploring the boundaries of the known world is what first attracted graduate student Archana Yerra to a career in science.

Jun 20, 2017

Grand Valley Oncology Announces Clinical Trials Open to Patients

Mesa County, Colo.--- Grand Valley Oncology with the support of Huntsman Cancer Institute (HCI) at the University of Utah will offer a range of clinical trials for their patients. Physicians at Grand Junction Oncology will work closely with their counterparts at HCI to identify opportunities for patients in western Colorado to participate in clinical trials.

Jun 09, 2017

New Cancer Drug Tested In Mice May Benefit Certain Leukemia Patients

SALT LAKE CITY –Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults. Scientists have found up to 30 percent of adult ALL patients have what’s called a Philadelphia chromosome, where two segments of chromosomes have aberrantly fused together. (The fusion chromosome is much less common in children.) Adult ALL patients exposed to standard treatments often see high relapse rates, and treatment-related deaths remain high. But researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered new science, published this week in the journal Leukemia, that could provide better therapeutic options for patients.

May 30, 2017

Huntsman Cancer Institute at the University of Utah Selected to Join National Cancer Institute’s Systems Biology Consortium

SALT LAKE CITY – Huntsman Cancer Institute (HCI) and the College of Pharmacy at the University of Utah (U of U) have been awarded a $9.1 million, five-year grant from the National Cancer Institute (NCI) to serve as a Research Center in NCI’s Cancer Systems Biology Consortium (CSBC). HCI is one of nine research institutions nationwide to be selected as a Research Center in the CSBC.

May 22, 2017

CEO of Huntsman Cancer Institute Inducted Alongside President Obama to American Philosophical Society

SALT LAKE CITY – Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute (HCI) at the University of Utah, has been elected to highly distinguished membership in the American Philosophical Society (APS), joining a group of 32 inductees that includes former United States president Barack Obama.

Apr 12, 2017

Huntsman Cancer Institute Investigators Elected to American Academy of Arts and Sciences

University of Utah professors Bradley R. Cairns, professor and chair of Oncological Sciences and senior director of Basic Science at Huntsman Cancer Institute; Dana Carroll, distinguished professor of Biochemistry and HCI investigator; and Christopher D. Hacon, distinguished professor of Mathematics, were raised to a high honor in science today with their election to the American Academy of Arts and Sciences.

Apr 11, 2017

Huntsman Cancer Institute Researchers Share Expertise at National Cancer Meeting

More than 20 researchers from Huntsman Cancer Institute (HCI) at the University of Utah made their mark on the American Association of Cancer Research (AACR) Annual Meeting this year. Held in Washington, D.C., the convention drew more than 21,500 cancer researchers from all over the world. Scientists attended sessions on topics from immunotherapy to precision medicine. About 15 researchers from HCI presented posters in the main conference hall, on a wide range of topics.

Mar 30, 2017

HCI CEO and Director Testifies before Congress on the Value of Federally-Funded Medical Research

Mary Beckerle, PhD, testified before the United States House of Representatives Committee on Oversight and Government Reform on the impact of federally-funded cancer research.

Feb 24, 2017

HCI Researcher Receives Merit Award for Prostate Cancer Research

Huntsman Cancer Institute researcher Andrew Hahn, MD, received the Conquer Cancer Foundation of ASCO Merit Award. The award recognizes young researchers who have made a significant impact to their field of study and promotes clinical cancer research by giving recipients the chance to present their findings at conferences.

Jan 25, 2017

Huntsman Cancer Institute Scientists Identify Bone Degradation Process Within Metastatic Breast Cancer

Once breast cancer spreads through the body, it can degrade a patient’s healthy bones, causing numerous problems. Scientists at Huntsman Cancer Institute (HCI) at the University of Utah have identified a new way that bones get destroyed through cancer. And they’ve also learned how to block that destruction with a new drug. Initial tests with patients show promising results.

Jan 12, 2017

Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study was published today in Cancer Cell. The findings suggest small cell lung cancer should not be treated as a uniform disease

Jan 10, 2017

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

Jan 01, 2017

HCI CEO and Director Serves as Panelist at White House Event

Mary Beckerle, PhD, CEO of Huntsman Cancer Institute, served as a panelist at an event organized by the White House Cancer Moonshot Task Force. Beckerle participated in a discussion on addressing disparities in access to cancer prevention, diagnosis, and treatment.

Dec 19, 2016

Huntsman Cancer Institute Leads International Colorectal Study

Huntsman Cancer Institute (HCI) at the University of Utah will head an international study to find out how lifestyle and other health factors impact colon and rectal cancer outcomes. HCI was awarded an $8.8 million grant from the National Institutes of Health to lead and expand an ongoing project in colon cancer research.

Oct 27, 2016

Promise of Better Targeted Treatments Now Possible in Children’s Brain Cancer

SALT LAKE CITY—More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Writing this week in the journal Cell Reports, researchers at Huntsman Cancer Institute (HCI) at the University of Utah report they have identified an existing group of drugs that appear to reduce or eliminate a certain subgroup of childhood brain cancers while sparing normal brain tissue. The research was conducted using a new zebrafish animal model system developed by the researchers, which closely resembles an aggressive subtype of pediatric brain tumors.

Oct 13, 2016

Born Rich or Poor? Where You Begin Life Affects Cancer Risk Later

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah announced today the results of a study that found that circumstances in childhood, such as parental occupation at birth and neighborhood income, may be associated with different risks of certain cancers later in life.

Sep 29, 2016

Huntsman Cancer Institute at the University of Utah Announces New Leadership

SALT LAKE CITY—Officials at University of Utah Health Care (UUHC) today announced that Ben Tanner, Huntsman Cancer Institute’s (HCI) current director of clinical operations and chief operating officer (COO) has been named the cancer hospital’s executive director, replacing Ray Lynch, who is retiring after 13 years of service. Tanner will assume his duties immediately.

Sep 14, 2016

Improving Cancer Prevention and Care among Underserved Individuals Focus of New Huntsman Center for HOPE

Huntsman Cancer Institute at the University of Utah today announced the creation of a new center to be housed in the soon-to-be-completed expansion of HCI’s research enterprise, the Primary Children’s and Families’ Cancer Research Center. The new center will be called the Huntsman Center for Health Outcomes and Population Equity (HOPE) and will focus on discovering new ways to prevent and treat cancer among underserved populations, including individuals living in poverty and residents of rural (between 6.1 and 99.9 persons/sq. mile) and frontier (<6.1 persons/sq. mile) areas.

Sep 13, 2016

Cancer Moonshot Blue Ribbon Panel Announces Recommendations

On September 7, 2016, National Cancer Institute (NCI) Acting Director Douglas Lowy, MD, accepted the recommendations of the Cancer Moonshot Blue Ribbon Panel (BRP) on a set of scientific approaches to accelerate progress in cancer research. An overview of the report was published in the journal Science.

Aug 26, 2016

New Report Says Having a Healthy Weight Lowers the Risk of More Cancers

People who are overweight or obese are at higher risk for more cancers than previously thought, says a report published in the New England Journal of Medicine August 25, 2016. The International Agency for Research on Cancer (IARC) brought together a group of 21 researchers from around the world to look at more than 1,000 studies linking excess body fat and cancer. Neli Ulrich, PhD, senior director of Population Sciences at Huntsman Cancer Institute (HCI), was a member of the group. Ulrich is a cancer researcher who studies lifestyle and biologic factors in cancer prevention and cancer prognosis.

Jul 05, 2016

HCI Convenes Cancer Moonshot Summit

Huntsman Cancer Institute (HCI) at the University of Utah participated in a national summit on the Cancer Moonshot initiative on June 29, 2016. The Cancer Moonshot Summits were organized at the request of Vice President Joe Biden, and more than 270 organizations hosted summits that brought together patients and survivors, researchers, physicians, advocates, philanthropists, and data and technology experts to brainstorm ways of speeding up progress in cancer prevention, diagnosis, treatment, and care over the next five years—and to ultimately end cancer as we know it.

Jun 23, 2016

HCI Plays Important Role in Cancer Moonshot Initiative

The Cancer Moonshot Initiative, launched during President Barack Obama’s 2016 State of the Union address and headed by Vice President Joe Biden, is generating excitement and hope in the world of cancer research and care. Huntsman Cancer Institute at the University of Utah is playing an important role in these efforts.

Jun 02, 2016

Oliver Sacks’ Rare Eye Disease Gives Rise to New Strategy for Treating Difficult Cancers

Eye cancer took the life of author and neurologist Oliver Sacks last year, bringing attention to the rare and deadly disease. Scientists have tried to develop precision treatments against cancers like this one, but the mutations that cause them have proven difficult to block with drugs.

Apr 25, 2016

What Is Cancer Control?

For National Cancer Control Month, Bridget Grahmann, BS, and Yelena Wu, PhD, of the Wu Team at Huntsman Cancer Institute explain what cancer control is and how it helps people with cancer as well as those who may never have it.

Apr 11, 2016

Giving Someone a One-in-a-Million Chance at Life

Bone marrow transplant patients at Huntsman Cancer Institute know all too well the importance of finding a donor who is a match. Maggie Kasten, a bone marrow donor and a research scientist in the Cairns Lab at HCI, also understands.

Apr 04, 2016

Huntsman Cancer Institute CEO to Join Federal Moonshot Blue Ribbon Panel

Huntsman Cancer Institute’s CEO and director, Mary Beckerle, PhD, has been asked to join Vice President Joe Biden’s Moonshot Program Initiative as an invited member of a new Blue Ribbon Panel, tasked with advising the National Cancer Advisory Board (NCAB) on the scientific opportunities available to accelerate progress against cancer and evaluate potential new investments in cancer research.

Mar 22, 2016

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patients

Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA), has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.

Feb 29, 2016

Huntsman Cancer Institute Hosts Vice President Joe Biden

(February 26, 2016) – Today Huntsman Cancer Institute (HCI) hosted Vice President Joe Biden as a part of the White House administration’s “moonshot” initiative to double the rate of progress toward curing cancer. During his visit, the vice president toured the facility, was given an inside look at the Utah Population Database and participated in a roundtable discussion comprised of Huntsman Cancer Foundation board chairman Jon Huntsman Jr., CEO and director of HCI Dr. Mary Beckerle and Senator Orrin Hatch. Local cancer survivors and physicians, researchers and experts in the field also participated in the roundtable.

Nov 19, 2015

Possible New Mechanism for Aspirin's Role in Cancer Prevention

Aspirin has been shown to decrease the risk of colorectal cancer and possibly other cancers. However, the risk of side effects, including in some cases severe gastrointestinal bleeding, makes it necessary to better understand the mechanisms by which aspirin acts at low doses before recommending it more generally as a preventative, says Cornelia Ulrich, PhD, Senior Director of Population Sciences at Huntsman Cancer Institute in Salt Lake City.

Jul 22, 2015

Poor Survival in Multiple Myeloma Patients Linked to Genetic Variation

As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it.

Apr 21, 2015

Study Finds Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults

Children with cancer have a good chance of surviving the disease—today more than 80% survive due to advances in treatment and care. However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.

Apr 13, 2015

Characterization of the Nutrient Needs of Triple Negative Breast Cancer Leads to the Identification of a Molecular Signature for Cancer Outcomes

Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. In a new study published in the journal Proceedings of the National Academy of Sciences (PNAS), researchers at Huntsman Cancer Institute and the University of Utah have identified a molecular mechanism that triple negative breast cancer cells use to survive and grow.

Apr 06, 2015

Noted UCSF Scientist Joins Research Team at Huntsman Cancer Institute

Martin McMahon, Ph.D., joins Huntsman Cancer Institute (HCI) at the University of Utah in August as Professor in the Department of Dermatology and HCI Senior Director of Pre-Clinical Translation. Professor McMahon is currently the Efim Guzik Distinguished Professor of Cancer Biology at the University of California, San Francisco and Assistant Director of Professional Education and Co-leader of the Helen Diller Family Comprehensive Cancer Center (HCFCCC) Developmental Therapeutics Program.

Jan 14, 2015

New Study Findings Help Physicians and Patients Determine Prostate Cancer Risk

A discovery by researchers at Huntsman Cancer Institute (HCI) shows that looking at whether a man’s uncles and great-grandparents, among other second- and third-degree relatives, had prostate cancer could be as important as looking at whether his father had prostate cancer. A more complete family history would give physicians a new tool to decide whether or not a PSA test was appropriate.

Jan 08, 2015

New Study Findings Help Physicians and Patients Determine Prostate Cancer Risk

A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man’s uncles and great-grandparents, among other second- and third-degree relatives, had prostate cancer could be as important as looking at whether his father had prostate cancer. A more complete family history would give physicians a new tool to decide whether or not a PSA test was appropriate.